{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:30Z","timestamp":1786988070533,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ejmech.2022.114816","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T19:32:33Z","timestamp":1664911953000},"page":"114816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Design, synthesis and activity evaluation of novel lesinurad analogues containing thienopyrimidinone or pyridine substructure as human urate transporter 1 inhibitors"],"prefix":"10.1016","volume":"244","author":[{"given":"Jian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruipeng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danhui","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7168-613X","authenticated-orcid":false,"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114816_bib1","first-page":"90","article-title":"The immunological basis in the pathogenesis of gout","volume":"14","author":"Chen","year":"2017","journal-title":"Iran J. Immunol."},{"key":"10.1016\/j.ejmech.2022.114816_bib2","first-page":"26","article-title":"Gout treatment: currents and perspectives","volume":"39","author":"Ghozlani","year":"2017","journal-title":"Revue Marocaine de Rhumatologie"},{"key":"10.1016\/j.ejmech.2022.114816_bib3","first-page":"73","article-title":"Review of the ophthalmic manifestations of gout and uric acid crystal deposition","volume":"45","author":"Jack","year":"2016","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ejmech.2022.114816_bib4","first-page":"1523","article-title":"Les bases physiopathologiques de la protection du myocarde isch\u00e9mique [Physiopathological basis of protection of the ischemic myocardium]","volume":"120","author":"Lerch","year":"1990","journal-title":"Schweiz. Med. Wochenschr."},{"key":"10.1016\/j.ejmech.2022.114816_bib5","first-page":"30","article-title":"Lipid metabolism study of hyperuricemia and gout arthritis based on lipidomics technology","volume":"16","author":"Yu","year":"2016","journal-title":"World Last Med. Info."},{"key":"10.1016\/j.ejmech.2022.114816_bib6","first-page":"1","article-title":"Effect of Eurycoma longifolia stem extract on uric acid excretion in hyperuricemia mice","volume":"33","author":"Rui-xia","year":"2019","journal-title":"Chin. J. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2022.114816_bib7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/15257770.2013.872274","article-title":"Hyperuricemia in hematologic malignancies is caused by an insufficient urinary excretion","volume":"33","author":"Oka","year":"2014","journal-title":"Nucleos Nucleot."},{"key":"10.1016\/j.ejmech.2022.114816_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","article-title":"Regulation of uric acid metabolism and excretion","volume":"213","author":"Maiuolo","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejmech.2022.114816_bib9","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1136\/annrheumdis-2011-201215","article-title":"Purine-rich foods intake and recurrent gout attacks","volume":"71","author":"Zhang","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejmech.2022.114816_bib10","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/art.41453","article-title":"Rising global burden of gout: time to act","volume":"72","author":"Danve","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ejmech.2022.114816_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejim.2015.03.008","article-title":"Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: a systematic review and meta-analysis of observational studies","volume":"26","author":"Ungprasert","year":"2015","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ejmech.2022.114816_bib12","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Gout Lancet."},{"key":"10.1016\/j.ejmech.2022.114816_bib13","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s40265-016-0595-y","article-title":"Pain relief for acute urolithiasis: the case for non-steroidal anti-inflammatory drugs","volume":"76","author":"Steinberg","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2022.114816_bib14","first-page":"27","article-title":"Gout: state of the art after a decade of developments","volume":"58","author":"Pascart","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejmech.2022.114816_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","volume":"375","author":"Richette","year":"2010","journal-title":"Gout Lancet."},{"key":"10.1016\/j.ejmech.2022.114816_bib16","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/acr.24180","article-title":"American college of rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.ejmech.2022.114816_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/13543784.2018.1471133","article-title":"Investigational drugs for hyperuricemia, an update on recent developments","volume":"27","author":"Pascart","year":"2018","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2022.114816_bib18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0006-2952(88)90739-3","article-title":"Oxypurinol as an inhibitor of xanthine oxidase-catalyzed production of superoxide radical","volume":"37","author":"Spector","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114816_bib19","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","article-title":"Effects of allopurinol on the progression of chronic kidney disease","volume":"382","author":"Badve","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2022.114816_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/13543776.2017.1261111","article-title":"An updated patent review: xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011-2015)","volume":"27","author":"Ojha","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2022.114816_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/14740338.2019.1594771","article-title":"Safety and tolerability of available urate-lowering drugs: a critical review","volume":"18","author":"Strilchuk","year":"2019","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.ejmech.2022.114816_bib22","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/j.jaip.2019.05.047","article-title":"Unique clinical characteristics and prognosis of allopurinol-induced severe cutaneous adverse reactions","volume":"7","author":"Park","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.ejmech.2022.114816_bib23","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/13543776.2019.1676727","article-title":"Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016-2019)","volume":"29","author":"Dong","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2022.114816_bib24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.phrs.2016.07.012","article-title":"Multidrug resistance-associated protein 4 (MRP4) controls ganciclovir intracellular accumulation and contributes to ganciclovir-induced neutropenia in renal transplant patients","volume":"111","author":"Billat","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2022.114816_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1152\/physrev.00025.2013","article-title":"The organic anion transporter (OAT) family: a systems biology perspective","volume":"95","author":"Nigam","year":"2015","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2022.114816_bib26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.xphs.2020.09.004","article-title":"Drug metabolites potently inhibit renal organic anion transporters, OAT1 and OAT3","volume":"110","author":"Zou","year":"2021","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2022.114816_bib27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature742","article-title":"Molecular identification of a renal urate anion exchanger that regulates blood urate levels","volume":"417","author":"Enomoto","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114816_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/BOR.0b013e328032781a","article-title":"New insights into renal transport of urate","volume":"19","author":"Anzai","year":"2007","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.ejmech.2022.114816_bib29","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3390\/biomedicines10030652","article-title":"Hypouricemia and urate transporters","volume":"10","author":"Otani","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2022.114816_bib30","doi-asserted-by":"crossref","first-page":"18175","DOI":"10.1073\/pnas.2006958117","article-title":"Identification of GLUT12\/SLC2A12 as a urate transporter that regulates the blood urate level in hyperuricemia model mice","volume":"117","author":"Toyoda","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2022.114816_bib31","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1021\/acsmedchemlett.0c00176","article-title":"Discovery of dotinurad (FYU-981), a new phenol derivative with highly potent uric acid lowering activity","volume":"11","author":"Uda","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114816_bib32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s40265-016-0550-y","article-title":"Lesinurad: first global approval","volume":"76","author":"Hoy","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2022.114816_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s42358-019-0080-x","article-title":"Benzbromarone in the treatment of gout","volume":"59","author":"Azevedo","year":"2019","journal-title":"Adv. Rheumatol."},{"key":"10.1016\/j.ejmech.2022.114816_bib34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2165\/00003495-198020030-00002","article-title":"Sulfinpyrazone: a review of its pharmacological properties and therapeutic use","volume":"20","author":"Margulies","year":"1980","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2022.114816_bib35","doi-asserted-by":"crossref","first-page":"C761","DOI":"10.1152\/ajpcell.00227.2008","article-title":"Probenecid, a gout remedy, inhibits pannexin 1 channels","volume":"295","author":"Silverman","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ejmech.2022.114816_bib36","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/ckj\/sfx036","article-title":"Lesinurad: what the nephrologist should know","volume":"10","author":"Sanchez-Ni\u00f1o","year":"2017","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.ejmech.2022.114816_bib37","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1093\/eurheartj\/ehab619","article-title":"Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout","volume":"42","author":"Kang","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejmech.2022.114816_bib38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/art.39840","article-title":"Lesinurad combined with allopurinol: a randomized, double-blind, placebo-controlled study in gout patients with an inadequate response to standard-of-care allopurinol (a US-based study)","volume":"69","author":"Saag","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ejmech.2022.114816_bib39","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0168-8278(94)80011-1","article-title":"Hepatic injury caused by benzbromarone","volume":"20","author":"van der Klauw","year":"1994","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejmech.2022.114816_bib40","series-title":"A Kind of Thienopyrimidinone Thioacetic Acid Derivatives and Preparation Method and Application Thereof","first-page":"7","author":"Liu","year":"2020"},{"key":"10.1016\/j.ejmech.2022.114816_bib41","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2174\/1573406412666160915163002","article-title":"Discovery of flexible naphthyltriazolylmethane-based thioacetic acids as highly active uric acid transporter 1 (URAT1) Inhibitors for the treatment of hyperuricemia of gout","volume":"13","author":"Zhang","year":"2017","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114816_bib42","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/molecules23020252","article-title":"Systematic structure-activity relationship (SAR) exploration of diarylmethane backbone and discovery of a highly potent novel uric acid transporter 1 (URAT1) inhibitor","volume":"23","author":"Cai","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114816_bib43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bmcl.2018.12.036","article-title":"Synthesis, biological evaluation and 3D-QSAR studies of 1,2,4-triazole-5-substituted carboxylic acid bioisosteres as uric acid transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia associated with gout","volume":"29","author":"Wu","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114816_bib44","doi-asserted-by":"crossref","first-page":"10829","DOI":"10.1021\/acs.jmedchem.0c00223","article-title":"Novel human urate transporter 1 inhibitors as hypouricemic drug candidates with favorable druggability","volume":"63","author":"Zhao","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114816_bib45","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1021\/acs.jmedchem.6b01437","article-title":"Recent advances in scaffold hopping","volume":"60","author":"Hu","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114816_bib46","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41598-017-00706-7","article-title":"Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout","volume":"7","author":"Tan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.114816_bib47","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1021\/acs.jmedchem.1c02057","article-title":"Discovery of novel bicyclic imidazolopyridine-containing human urate transporter 1 inhibitors as hypouricemic drug candidates with improved efficacy and favorable druggability","volume":"65","author":"Zhao","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114816_bib48","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1021\/cr950066q","article-title":"Bioisosterism: a rational approach in drug design","volume":"96","author":"Patani","year":"1996","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2022.114816_bib49","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/polym11020346","article-title":"Effect of side chain length on polycarboxylate superplasticizer in aqueous solution: a computational study","volume":"11","author":"Chuang","year":"2019","journal-title":"Polymers"},{"key":"10.1016\/j.ejmech.2022.114816_bib50","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/cbdd.12751","article-title":"Arylazolyl(azinyl)thioacetanilides: Part 19: discovery of novel substituted imidazo[4,5-b]pyridin-2-ylthioacetanilides as potent HIV NNRTIs via a structure-based bioisosterism approach","volume":"88","author":"Li","year":"2016","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2022.114816_bib51","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.bmcl.2005.02.005","article-title":"Structure-activity relationship study of novel tissue transglutaminase inhibitors","volume":"15","author":"Duval","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114816_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109195","article-title":"Curcumin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation in mice","volume":"118","author":"Chen","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2022.114816_bib53","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41584-019-0222-x","article-title":"Mouse models for human hyperuricaemia: a critical review","volume":"15","author":"Lu","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.ejmech.2022.114816_bib54","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1021\/jm1015022","article-title":"Developing potent human uric acid transporter 1 (hURAT1) inhibitors","volume":"54","author":"Wempe","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114816_bib55","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/mt.2015.187","article-title":"Production of recombinant adeno-associated virus vectors using suspension HEK293 cells and continuous harvest of vector from the culture media for GMP FIX and FLT1 clinical vector","volume":"24","author":"Grieger","year":"2016","journal-title":"Mol. Ther."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422007188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422007188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:46:31Z","timestamp":1759329991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422007188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":55,"alternative-id":["S0223523422007188"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114816","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and activity evaluation of novel lesinurad analogues containing thienopyrimidinone or pyridine substructure as human urate transporter 1 inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114816"}}